Helen Of Troy (HELE) Q4 2026 Earnings Transcript

Helen of Troy reported Q4 net sales down 3.3% and adjusted operating margin down 710bps to 8.3%, but results came in at the favorable end of guidance and free cash flow reached $132 million for FY2026. Fiscal 2027 guidance calls for net sales of $1.751B-$1.822B, adjusted EBITDA of $190M-$197M, and EPS of $3.25-$3.75, while tariff-related risks remain elevated and management is factoring in roughly $50M of price-mix benefit and a 40bps increase in growth investment. The company also highlighted $78M of proceeds from the Southaven facility sale and plans to reduce China-tariff exposure below 20% of COGS next year.

Analysis

The market is still treating HELE like a cyclical consumer rerate, but the more important read-through is supply-chain normalization is being weaponized into a margin recovery story. If management executes even halfway on dual-sourcing and China mix reduction, tariff sensitivity should step down materially over the next 2-3 quarters, which matters more than the headline guide because it creates operating leverage on a much cleaner cost base. That also shifts bargaining power: retailers that previously forced promotional concessions may see less room to push back once HELE’s dependence on last-minute imports and inventory air pockets declines.

The near-term risk is that the company is effectively underwriting a second-half inflection while absorbing a first-half cost wall from tariff cycling, pricing lag, and the Iran-linked resin/freight shock. The key second-order effect is not just higher input costs, but potential disruption to service levels if the company over-hedges or forward-buys into a sharp demand slowdown; that would convert a cost problem into a working-capital problem. Watch for any signs that freight and resin are being passed through to retailers slower than expected — that would hit gross margin before the pricing benefit shows up in revenue.

Contrarian take: the consensus may be underestimating how much of the “growth investment” is actually a prerequisite for restoring credibility with retailers and consumers, not merely discretionary spend. If OXO/Hydro Flask/Osprey continue to take share while Beauty stabilizes, the business can re-rate on forward FCF rather than near-term EPS, especially with leverage trending toward the low-3x area. But if category demand stays weak and promotional intensity rises, the plan becomes a longer-duration deleveraging story with limited multiple support.

The cleanest setup is a tactical long only after evidence of second-half demand inflection or a pullback tied to macro fears, because the stock now has more binary sensitivity to cost shocks than to the long-term roadmap. The company’s forward FCF yield framing is credible only if working capital keeps cooperating; any inventory build would quickly invalidate the bull case.

Key Decisions for Investors

• Long HELE on a pullback over the next 2-6 weeks only if management commentary holds and commodity/freight spikes look transitory; target a re-rating toward forward FCF yield peers, but cut if inventory stops declining or leverage stalls above 3.5x.
• Pair trade: long HELE / short a retailer-exposed discretionary basket for 3-6 months if you want exposure to supply-chain normalization and pricing power while reducing consumer-demand beta.
• Sell downside hedges into the first implied-vol spike: buy HELE puts or put spreads around the next macro/risk-event window if the market starts pricing the Iran shock as persistent; the risk/reward improves if spot weakness is driven by input-cost fear rather than demand deterioration.
• Avoid chasing into strength until there is evidence that first-half EPS compression is being offset by real POS improvement; the guide implies limited near-term upside and the stock likely needs a clean data point before multiple expansion.
• Monitor WMT and TGT channel checks: if both keep accepting price without meaningful volume erosion, that is a bullish leading indicator for HELE margin recovery and a signal to add on confirmation.